Clinical Trial 51659

Berlin, NJ 08009


A Phase 3, Randomized, Placebo-Controlled, Observer-Blinded Trial to Evaluate the Safety of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15) in Healthy Children 5 Through 17 Years of Age

  • Be 5-17 years old
  • Be in general good health
  • Have no previous vaccine for Lyme Disease
  • Additional criteria apply

Qualified Participants May Receive:

  • Study-related care at no cost
  • Compensation up to $800 for time and trial-related travel expenses

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.